Key Client Fiduciary Advisors »

Leap Therapeutics shares owned by Key Client Fiduciary Advisors

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Key Client Fiduciary Advisors from 13F filings

Historical chart of Key Client Fiduciary Advisors investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Key Client Fiduciary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Key Client Fiduciary Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $620k 233k 2.66
2023-12-31 $890k 215k 4.15
2023-09-30 $314k 227k 1.38
2023-06-30 $496k 159k 3.13

More positions owned by Key Client Fiduciary Advisors

Microsoft Corporation (MSFT)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Apple (AAPL)
First Tr Exchange-traded Indxx Aerospace (MISL)
First Tr Morningstar Divid L SHS (FDL)
First Tr Value Line Divid In SHS (FVD)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Prudential Financial (PRU)
Annaly Capital Management In Com New (NLY)
Abbvie (ABBV)

View all positions for Key Client Fiduciary Advisors

Top funds holding Leap Therapeutics

Baker Bros. Advisors
Citadel Advisors
Samsara BioCapital
683 Capital Management
Vanguard Group
Key Client Fiduciary Advisors
T. Rowe Price Associates
Alyeska Investment Group
Perceptive Advisors
Hrt Financial
Advisor Group Holdings
Baystate Wealth Management
Simplex Trading
CNB Bank
UBS Group

View all funds holding Leap Therapeutics